My thinking for these conservative numbers is that 1 patient has been treated and assessed.
Reasoning is that you want to observe (and understand) how the first patient responds. As an analogy in engineering you test a first article (first in production) before moving to production and testing of following articles in a production series. It's a cautious/methodical approach.
Pillar 3 - AML, page-109
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.005(0.32%) |
Mkt cap ! $260.8M | |||
| Open | High | Low | Value | Volume |
| $1.54 | $1.56 | $1.53 | $117.3K | 76.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10007 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 3335 | 1 |
View Market Depth
| Last trade - 11.01am 05/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |